Details

Understanding complex biology at scale requires more than one proteomics approach. In this live webinar, discover how integrating Mass Spectrometry with NGS‑powered large‑scale proteomics enables both depth and population‑scale coverage, unlocking biological insight that single‑platform workflows cannot deliver.

Join Vincent Albrecht, PhD (Max Planck Institute of Biochemistry) as he shows how scalable, complementary proteomics technologies work together to capture dynamic proteome information across large cohorts, from high‑resolution molecular detail to broad population‑level profiling.
 

Agenda

Introduction into proteomics at scale – Dr. Jan Rieger, Illumina, 10 min
From Acute Response to Trained Phenotype: Multi-Platform Plasma Proteomics of Elite Athletes – Dr. Vincent Albrecht, Max Planck Institute of Biochemistry, Germany, 25 min
Live Q&A and panel discussion, 15 min
 

What you’ll learn

In this webinar, you’ll see how combining proteomics platforms can:

  • Reveal deeper biological insight through complementary Mass Spectrometry and NGS‑based proteomics
  • Enable scalable plasma proteomics without compromising resolution
  • Support population‑level studies while maintaining biological depth
  • Bridge technology innovation with real‑world physiological research
     
About the speaker

Vincent Albrecht
Postdoctoral Researcher, Proteomics and Signal Transduction department of Prof. Matthias Mann, Max Planck Institute of Biochemistry

During his PhD, Vincent developed scalable workflows for deep plasma proteomics, including the PCA‑N method, enabling large cohort studies with dramatically reduced cost and sample requirements. His research focuses on applying these technologies across diverse clinical and physiological contexts, from large translational cohorts to the multi-platform study of exercise adaptation in elite athletes.

Vincent is an active member of the HUPO Human Plasma Proteome Project and the HUPO Early Career Researcher Committee.

 

M-EMEA-02216

Register

Your email address is never shared with third parties.

Date & Time
4 Jun 2026
01:00 PM
Location
Europe
Topic
Genetic & rare diseases
Register